Participation in scheduled asthma follow-up contacts and adherence to treatment during 12-year follow-up in patients with adult-onset asthma
Authors:
Open Access
- 15 February 2022
- journal article
- research article
- Published by Springer Nature in BMC Pulmonary Medicine
- Vol. 22 (1) , 1-12
Abstract
Background: Poor treatment compliance is a common problem in the treatment of asthma. To our knowledge, no previous long-term follow-up studies exist on how scheduled asthma follow-up contacts occur in primary health care (PHC) versus secondary care and how these contacts relate to adherence to medication and in participation to further scheduled asthma contacts. The aim of this study was to evaluate occurrence of scheduled asthma contacts and treatment compliance in PHC versus secondary care, and to identify the factors associated with non-participation to scheduled contacts. Methods: Patients with new adult-onset asthma (n = 203) were followed for 12 years in a real-life asthma cohort of the Seinäjoki Adult Asthma Study (SAAS). The first contacts were mainly carried out in secondary care and therefore the actual follow-up time including PHC visits was 10 years. Results: A majority (71%) of the patients had ≥ 2 scheduled asthma contacts during 10-year follow-up and most of them (79%) mainly in PHC. Patients with follow-up contacts mainly in PHC had better adherence to inhaled corticosteroid (ICS) medication during the whole 12-year period compared to patients in secondary care. In the study population, 29% of the patients had only 0–1 scheduled asthma contacts during the follow-up. Heavy alcohol consumption predicted poor participation in scheduled contacts. Conclusions: Patients with mainly PHC scheduled asthma contacts were more adherent to ICS medication than patients in the secondary care. Based on our results it is necessary to pay more attention to actualization of asthma follow-up visits and systematic assessment of asthma patients including evaluation of alcohol consumption. Trial registration Seinäjoki Adult Asthma Study is retrospectively registered at www.ClinicalTrials.gov with identifier number NCT02733016. Registered 11 April 2016.Keywords
Funding Information
- The Allergy Research Foundation, Finland
- Tampereen Tuberkuloosisäätiö
- Hengityssairauksien Tutkimussäätiö
- The Pihkahovi Foundation
- Suomen Tuberkuloosin Vastustamisyhdistyksen Säätiö
- Ida Montinin Säätiö
- Pirkanmaan Rahasto
- The Competitive State Research Financing of the Expert Responsibility Area of Tampere University Hospital, Finland
- Medical Research Fund of Seinäjoki Central Hospital, Finland
This publication has 39 references indexed in Scilit:
- Adherence to inhaled therapies, health outcomes and costs in patients with asthma and COPDRespiratory Medicine, 2013
- Adult-Onset Asthma Becomes the Dominant Phenotype among Women by Age 40 Years. The Longitudinal CARDIA StudyAnnals of the American Thoracic Society, 2013
- Key findings and clinical implications from The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) studyJournal of Allergy and Clinical Immunology, 2012
- Asthma Programme in Finland: Did the use of secondary care resources become more rational?Respiratory Medicine, 2010
- Alcohol use of diabetes patients: the need for assessment and interventionActa Diabetologica, 2010
- Primary health care centres with asthma clinics: effects on patients' knowledge and asthma controlPrimary Care Respiratory Journal, 2009
- COMPARISON OF THE COMBINED MARKER GGT–CDT AND THE CONVENTIONAL LABORATORY MARKERS OF ALCOHOL ABUSE IN HEAVY DRINKERS, MODERATE DRINKERS AND ABSTAINERSAlcohol and Alcoholism, 2006
- Development of the asthma control testJournal of Allergy and Clinical Immunology, 2004
- Asthma health status measurement in clinical practice: validity of a new short and simple instrumentRespiratory Medicine, 1998
- INTRODUCTIONClinical & Experimental Allergy, 1996